Progressive Care (OTCQB: RXMD), a personalized healthcare services and technology provider, is reporting its financial results for the first quarter ended March 31, 2023. According to the report, the company saw record quarterly revenue; the report showed a $11.4 million revenue for the first quarter, a 13% increase from the first quarter ended March 31, 2022. Other highlights include total pharmacy revenue increasing by $1.3 million, or 13%; prescription revenue increased by $1.8 million, or 21%, to total $10.4 million during the first quarter of 2023; 340B contract revenue for the quarter was $1.6 million, an increase of $1.2 million; gross profit margin increased 28% for the three months ended March 31, 2023; and cash balance at the end of the quarter was an estimated $7.5 million compared to $6.7 million at December 31, 2022. The company also noted key organizational milestones reached during the quarter, including the appointment of Dr. Pamela Roberts as COO and the successful completion of $1 million investment from NextPlat Corp. “We had a net loss of approximately $0.1 million and $1.4 million for the three months ended March 31, 2023 and 2022, respectively,” the report stated. “The decrease in net loss is attributable to nonoperating items primarily recorded in the prior year period such as the adverse change in the fair value of derivative liabilities, as well as the decrease in interest expense period over period.”
To view the full press release, visit https://ibn.fm/uPQ9W
About Progressive Care
Progressive Care, through its subsidiaries, is a Florida health services organization and provider of Third-Party Administration (TPA), data management, COVID-19 related diagnostics and vaccinations, 340B contracted pharmacy services, prescription pharmaceuticals, compounded medications, provider of telepharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management. For more information about the company, visit www.ProgressiveCareUS.com
NOTE TO INVESTORS: The latest news and updates relating to RXMD are available in the company’s newsroom at https://ibn.fm/RXMD
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork